Related Experiment Video
Updated: Dec 20, 2025

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Out of hospital management of LVAD patients during COVID-19 outbreak
Silvia Mariani1, Jasmin S Hanke1, Günes Dogan1
1Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Insights
The COVID-19 pandemic risks care for patients with left ventricular assist devices (LVADs). A new telemonitoring algorithm ensures continuous care and timely recognition of complications for these vulnerable patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Medical Technology
Background:
- Patients with left ventricular assist devices (LVADs) have complex cardiovascular conditions requiring close monitoring.
- The COVID-19 pandemic disrupted routine clinical care, increasing risks for LVAD patients.
- Reduced healthcare access can lead to delayed complication recognition and misdiagnosis in LVAD patients.
Purpose of the Study:
- To design a sustainable and adaptable telemonitoring algorithm for LVAD patients during the COVID-19 pandemic.
- To maintain optimal quality of care and mitigate risks associated with reduced clinical activity.
- To address the challenges of remote patient management in a pandemic setting.
Main Methods:
- Development of a telemonitoring algorithm tailored for LVAD patients.
- Implementation within a large-scale LVAD program.
- Focus on adaptability for widespread adoption across different LVAD centers.
Main Results:
- The designed algorithm provides a sustainable framework for remote patient monitoring.
- It facilitates the maintenance of high-quality care for LVAD patients.
- The approach is adaptable to various LVAD programs, ensuring broader applicability.
Conclusions:
- Telemonitoring is crucial for ensuring continuous care for LVAD patients during pandemics.
- The developed algorithm offers a practical solution to maintain patient safety and well-being.
- Adapting care models through technology is essential for managing vulnerable populations during health crises.
Abstract:
Coronavirus disease 2019 (COVID-19) is a pandemic touching thousands of people all around the world. Patients supported with left ventricular assist devices (LVADs) are affected by long-standing cardiovascular diseases and subjected to variations of the normal cardiovascular physiology, thus requiring an even closer monitoring during the COVID-19 outbreak. Nevertheless, the COVID-19 pandemic led to a drastic reduction in routine clinical activities and a consequent risk of looser connections between LVAD patients and their referring center. Potential deleterious effects of such a situation can be a delayed recognition of LVAD-related complications, misdiagnosis of COVID-19, and impaired social and psychological well-being for patients and families. As one of the largest LVAD programs worldwide, we designed a sustainable and enforceable telemonitoring algorithm which can be easily adapted to every LVAD center so as to maintain optimal quality of care for LVAD patients during the COVID-19 pandemic.
More Related Videos
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
03:40Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiopulmonary Resuscitation II: ACLS Airway Management
Acute Coronary Syndrome V: Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Aortic Regurgitation IV: Nursing Management
Cardiac Catheterization IV: Nursing Management